MAXERAN trademark

MAXERAN - Trademark Information

Trademark by SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE DE FRANCE

The MAXERAN trademark was assigned a Serial Number #73803728 – by the United States Patent and Trademark Office (USPTO). Trademark Serial Number is a unique ID to identify the MAXERAN mark in USPTO. The MAXERAN mark is filed in the category of Pharmaceuticals. The legal correspondent for MAXERAN trademark is JOHN THOMAS CELLA, FITZPATRICK, CELLA, HARPER & SCINTO, 277 PARK AVE, NEW YORK, NEW YORK UNITED STATES 10172 Domestic Representative . The current status of the MAXERAN filing is Registration cancelled because registrant did not file an acceptable declaration under Section 8..

Based on SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE DE FRANCE, the MAXERAN trademark is used in the following business: METOCLOPRAMIDE FOR THE RELIEF OF EMESIS AND TO IMPROVE DIGESTION.

TrademarkTok is the largest free online trademark search, trademark monitoring, and tracking platform. We provide online software to streamline the process, helping clients do trademark & patent searches, applications, and monitoring more automatically and efficiently. You can create a free account on TrademarkTok.com and monitor all of your trademarks from one convenient dashboard, and receive free status updates any time when the status is changed.

Have a Name, Slogan, or Logo to protect? TrademarkTok, an Experienced IP Agent Made It Easy - Trademark Registration in 180 Countries.

Set up your brands for success! The United States is the most difficult country in the world to register a trademark. The trademark process in the United States takes approximately one year and is fraught with pitfalls. Approximately 60% of all applications receive a refusal. Many of these refusals can be overcome by strategic work of an experienced IP consultant, but DIY-applications generally are NOT successful.

We have extensive expertise in intellectual property law, including but not limited to trademark, copyright, and patent matters in multiple countries. You can count on our vast experience in filing trademark applications and trademark maintenance to help get your trademark protected properly, cost-effectively and efficiently.

Select the Filing Country:

Trademark Registration in USA

$199

$199 + Govt Fee* (1 class)

STANDARD PACKAGE

Basic Direct-Hit Searchto help avoid obvious duplications of pre-existing marks.
Professional Preparationof your trademark application.
Electronic Deliveryof your trademark application with no need to wait for mail or dealing with paper files. This will qualify you the reduced government filing fee.
Free Search & Evaluation on Alternative Mark if Your Attorney Thinks There's an Issue with Your First Choice.

* The Trademark government fee will be charged when we submit your mark(s) to the Government Trademark Office, which is usually in the next few business days.

SERIAL NUMBER
73803728
WORD MARK
MAXERAN
CURRENT STATUS
Registration cancelled because registrant did not file an acceptable declaration under Section 8.
STATUS DATE
Monday, May 05, 1997
FILING DATE
Thursday, June 01, 1989
PRIORITY-CLAIM INTERNATIONAL FILING DEADLINE:

December 01, 1989
(PRIORITY CLAIM MUST BE FILED WITHIN SIX MONTHS OF FOREIGN FILING)
Trademarks are territorial. US trademark registration will not protect your trademark in a foreign country. If you have plan to protect your trademark internationally, see more options below :
REGISTRATION NUMBER
1619373
REGISTER TYPE
Principal
TRADEMARK OWNER
46, BOULEVARD DE LATOUR-MAUBOURG, PARIS FRANCE
Owner Type: CORPORATION
TRADEMARK CORRESPONDENT
FITZPATRICK, CELLA, HARPER & SCINTO, 277 PARK AVE, NEW YORK, NEW YORK UNITED STATES 10172 Domestic Representative
Trademark Classification Information
CLASS INFO
Class 005 - Pharmaceuticals

First Use Anywhere:
First Use in Commerce:
Trademark Goods and Services Description
DESCRIPTION
Class 005 - METOCLOPRAMIDE FOR THE RELIEF OF EMESIS AND TO IMPROVE DIGESTION

Start Trademark Search

Search Now

Current Status:

Registration cancelled because registrant did not file an acceptable declaration under Section 8.

5/5/1997